Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Scientists have developed SMART (silently mutate and repair template), a strategy that dramatically expands the editable ...

The U.S. military is interested in ‘super spiders’ capable of producing silk with extraordinary features. Don’t worry—it ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Assistant Professor Andy Tay (right), Mr Arun Kumar (left) and their team have developed an innovative 'food delivery service ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Researchers at the National University of Singapore have developed a scalable, non-viral technology that efficiently delivers ...

Ask scientists which gene-editing tool is most needed to advance gene therapy, and they'd probably describe a system that's now close to realization in the labs of Samuel Sternberg at Columbia ...

Market Segmentation: The report may break down the market into segments based on gene delivery methods (e.g., viral vectors, non-viral vectors), applications (e.g., gene therapy, research, vaccines), ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...